Pierre Poitras Selected Research

Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison)

1/2017	Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.
8/2013	Secretin stimulation test for gastrin release in Zollinger-Ellison syndrome: to do or not to do?
5/2012	Pitfalls in diagnostic gastrin measurements.
2/2012	The Zollinger-Ellison syndrome: dangers and consequences of interrupting antisecretory treatment.
5/2011	The Zollinger-Ellison syndrome and mismeasurement of gastrin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Poitras Research Topics

Disease

5	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 01/2017 - 05/2011
3	Gastrinoma 01/2017 - 05/2011
2	Crohn Disease (Crohn's Disease) 01/2021 - 10/2015
2	Ulcerative Colitis 01/2021 - 10/2015
2	Hypersensitivity (Allergy) 06/2002 - 04/2002
1	Intestinal Polyposis (Polyposis, Intestinal) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017
1	Colitis 10/2015
1	Esophageal Motility Disorders (Nutcracker Esophagus) 01/2015
1	Fatigue 08/2008
1	Sleep Wake Disorders 08/2008
1	Dyspepsia (Indigestion) 01/2006
1	Gastroparesis 09/2005
1	Ileus 09/2005
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2002
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 06/2002

Drug/Important Bio-Agent (IBA)

4	GastrinsIBA 01/2017 - 05/2011
2	Dihydrotachysterol (AT 10)IBA 01/2021 - 09/2005
2	Proton Pump InhibitorsIBA 01/2017 - 02/2012
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	AcidsIBA 01/2017
1	2-mercaptopurineIBA 10/2015
1	golimumab FDA Link 10/2015
1	vedolizumabIBA 10/2015
1	Adalimumab (Humira)FDA Link 10/2015
1	Infliximab (Remicade)FDA Link 10/2015
1	Natalizumab (Tysabri)FDA Link 10/2015
1	Ustekinumab (CNTO 1275)FDA Link 10/2015
1	Azathioprine (Imuran)FDA LinkGeneric 10/2015
1	Methotrexate (Mexate)FDA LinkGeneric 10/2015
1	LeptinIBA 01/2015
1	Secretin FDA Link 08/2013
1	AmidesIBA 05/2012
1	Peptides (Polypeptides)IBA 05/2012
1	Pharmaceutical PreparationsIBA 08/2008
1	Cholinergic Agents (Cholinergics)IBA 01/2006
1	Opiate AlkaloidsIBA 09/2005
1	Morphine (MS Contin)FDA LinkGeneric 09/2005
1	RC-1139IBA 09/2005
1	Biomarkers (Surrogate Marker)IBA 06/2002
1	antineoplaston A10 (A 10)IBA 04/2002
1	Biological ProductsIBA 04/2002

Therapy/Procedure

2	Therapeutics 10/2015 - 05/2011
1	Restorative Proctocolectomy 01/2021